News and Analysis

Carisma Therapeutics nabs $59m Series B

Carisma Therapeutics Inc., a biopharmaceutical company, has raised $59 million in Series B funding.

-

Carisma Therapeutics Inc., a biopharmaceutical company, has raised $59 million in Series B funding. The investors include IP Group Inc, Penn Medicine and 4BIO Capital.

Source: Press Release